Benmoxin

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]

Benmoxin

Clinical data
Routes of administration	Oral
ATC code	None
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name N'-(1-phenylethyl)benzohydrazide
CAS Number	7654-03-7^N
PubChem CID	71671
ChemSpider	64728^Y
UNII	XC9FY2SGBG
ChEMBL	ChEMBL1877495^N
CompTox Dashboard (EPA)	DTXSID0046220
ECHA InfoCard	100.028.745
Chemical and physical data
Formula	C15H16N2O
Molar mass	240.306 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C(NNC(c1ccccc1)C)c2ccccc2
InChI InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18)^Y Key:BEWNZPMDJIGBED-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

See also

• Hydrazine (antidepressant)

References

1. Ganellin, C. R.; Triggle, David J. (1996). Dictionary of Pharmacological Agents, Volumes 1-2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.
2. Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.